The Lin Family is an entrepreneurial family from Taiwan and the founding family behind Intai Technology Corporation (TWSE: 4163), a publicly listed company. With over 30 years of industry experience, the family has a strong foundation in precision manufacturing and medical technology.

Committed to integrity and sustainable development, the Lin Family continues to invest in Taiwan’s industrial growth and transformation—particularly through strategic deployment of high-tech and biomedical real estate assets.

The family’s core philosophy is:

“Creating value through industry, passing on beliefs through assets.”

About Me – Daniel Lin

Hello, I’m Daniel Lin (pictured on the far left), second-generation member of the Lin Family. I currently assist with family asset management and investment evaluation. With a background in the healthcare industry and international business, I have spent many years living in the United States and am well-versed in cross-border industrial development, biomedical innovation, and real estate trends between Taiwan and the U.S.

In the past, I’ve been involved in expanding our family business internationally and have also ventured into healthcare startups, founding companies focused on AI and cell therapy. These experiences have equipped me with not only strong asset management skills, but also a deep understanding of how industries and markets interact and evolve.

Why I’m presenting this investment opportunity

I’m currently assisting my family in promoting our newly completed property in Zhubei Biomedical Park. This project is part of the Lin Family’s long-term investment strategy—and also a reflection of my personal belief in the synergy between technology industries and tangible assets.

This is more than just a real estate offering. It’s an opportunity to help forward-thinking biotech and medical companies, teams, or investors secure a strategic foothold for the future.